Osteopontin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Osteopontin" in English language version.

refsWebsite

Global rank English rank

148nih.gov

4^th place

101doi.org

2^nd place

31semanticscholar.org

11^th place

8^th place

10harvard.edu

18^th place

17^th place

2ensembl.org

1,626^th place

1,007^th place

1rutgers.edu

1,999^th place

1,355^th place

1zenodo.org

621^st place

380^th place

1bbc.co.uk

8^th place

10^th place

bbc.co.uk

news.bbc.co.uk

Mori R, Shaw TJ, Martin P (January 2008). "Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring". The Journal of Experimental Medicine. 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- "Gel 'to speed up wound healing'". BBC News. 22 January 2008.

doi.org

Kalmar L, Homola D, Varga G, Tompa P (September 2012). "Structural disorder in proteins brings order to crystal growth in biomineralization". Bone. 51 (3): 528–534. doi:10.1016/j.bone.2012.05.009. PMID 22634174.
Wang KX, Denhardt DT (2008). "Osteopontin: role in immune regulation and stress responses". Cytokine & Growth Factor Reviews. 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.
Rangaswami H, Bulbule A, Kundu GC (February 2006). "Osteopontin: role in cell signaling and cancer progression". Trends in Cell Biology. 16 (2): 79–87. doi:10.1016/j.tcb.2005.12.005. PMID 16406521.
Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). "cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)". Genomics. 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876.
Kiefer MC, Bauer DM, Barr PJ (April 1989). "The cDNA and derived amino acid sequence for human osteopontin". Nucleic Acids Research. 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
Crosby AH, Edwards SJ, Murray JC, Dixon MJ (May 1995). "Genomic organization of the human osteopontin gene: exclusion of the locus from a causative role in the pathogenesis of dentinogenesis imperfecta type II". Genomics. 27 (1): 155–160. doi:10.1006/geno.1995.1018. PMID 7665163.
Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, et al. (March 2013). "Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia". Journal of Bone and Mineral Research. 28 (3): 688–699. doi:10.1002/jbmr.1766. PMID 22991293. S2CID 20840491.
Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). "Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis". The Journal of Clinical Investigation. 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). "Osteopontin--a possible anchor of osteoclasts to bone". Proceedings of the National Academy of Sciences of the United States of America. 87 (12): 4473–5. Bibcode:1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Banerjee A, Apte UM, Smith R, Ramaiah SK (March 2006). "Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease". The Journal of Pathology. 208 (4): 473–485. doi:10.1002/path.1917. PMID 16440289. S2CID 45879742.
Sodek J, Batista Da Silva AP, Zohar R (May 2006). "Osteopontin and mucosal protection". Journal of Dental Research. 85 (5): 404–415. doi:10.1177/154405910608500503. PMID 16632752. S2CID 25898774.^{[permanent dead link‍]}
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (July 2000). "Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration". Journal of Cellular Physiology. 184 (1): 118–130. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. PMID 10825241. S2CID 11548419.
Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (August 2002). "Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts". Journal of Bone and Mineral Research. 17 (8): 1486–97. doi:10.1359/jbmr.2002.17.8.1486. PMID 12162503. S2CID 21307088.
Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J (January 2004). "Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin". Journal of Cellular Physiology. 198 (1): 155–167. doi:10.1002/jcp.10394. PMID 14584055. S2CID 21075107.
Junaid A, Moon MC, Harding GE, Zahradka P (February 2007). "Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1". American Journal of Physiology. Cell Physiology. 292 (2): C919 – C926. doi:10.1152/ajpcell.00477.2006. PMID 17005603.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). "Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells". Proceedings of the National Academy of Sciences of the United States of America. 105 (20): 7235–9. Bibcode:2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
He B, Mirza M, Weber GF (April 2006). "An osteopontin splice variant induces anchorage independence in human breast cancer cells". Oncogene. 25 (15): 2192–2202. doi:10.1038/sj.onc.1209248. PMID 16288209. S2CID 6632395.
Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF (February 2008). "Osteopontin-c is a selective marker of breast cancer". International Journal of Cancer. 122 (4): 889–897. doi:10.1002/ijc.23204. PMID 17960616. S2CID 22146646.
Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, et al. (November 1996). "Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction". The Journal of Clinical Investigation. 98 (10): 2218–27. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). "Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta". The Journal of Clinical Investigation. 92 (6): 2814–20. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, Pagel CN (April 2008). "Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro". The International Journal of Biochemistry & Cell Biology. 40 (10): 2303–14. doi:10.1016/j.biocel.2008.03.020. PMID 18490187.
Merry K, Dodds R, Littlewood A, Gowen M (April 1993). "Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone". Journal of Cell Science. 104 (4): 1013–20. doi:10.1242/jcs.104.4.1013. PMID 8314886.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (January 2002). "The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation". Cell. 108 (1): 17–29. doi:10.1016/S0092-8674(01)00622-5. PMID 11792318. S2CID 14030684.
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (May 1997). "Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation". Cell. 89 (5): 747–754. doi:10.1016/S0092-8674(00)80257-3. PMID 9182762. S2CID 16979723.
Prince CW, Butler WT (September 1987). "1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells". Collagen and Related Research. 7 (4): 305–313. doi:10.1016/s0174-173x(87)80036-5. PMID 3478171.
Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). "Regulation of bone sialoprotein mRNA by steroid hormones". The Journal of Cell Biology. 109 (6 Pt 1): 3183–6. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
Pereira TA, Vaz de Melo Trindade G, Trindade Santos E, Pereira FE, Souza MM (May 2021). "Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni". International Journal for Parasitology. 51 (6): 437–440. doi:10.1016/j.ijpara.2020.11.002. PMID 33493521. S2CID 231711719.
Gill HS, LeJambre LF (1996). "Preface — Novel approaches to the control of helminth parasites of livestock. Proceedings of an international conference. Armidale, New South Wales, 18-21 April 1995". Int J Parasitol. 26 (8–9): 797–8. doi:10.1016/S0020-7519(96)80042-7. PMID 8923128.
Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). "Phosphate regulates osteopontin gene transcription". Journal of Dental Research. 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
Guo H, Cai CQ, Schroeder RA, Kuo PC (January 2001). "Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages". Journal of Immunology. 166 (2): 1079–86. doi:10.4049/jimmunol.166.2.1079. PMID 11145688.
Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR (May 2000). "Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells". American Journal of Physiology. Renal Physiology. 278 (5): F708 – F716. doi:10.1152/ajprenal.2000.278.5.F708. PMID 10807582.
Noda M, Rodan GA (February 1989). "Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone". The Journal of Cell Biology. 108 (2): 713–8. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ (January 2001). "TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements". Experimental Cell Research. 262 (1): 69–74. doi:10.1006/excr.2000.5074. PMID 11120606.
Sodhi CP, Phadke SA, Batlle D, Sahai A (April 2001). "Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin". American Journal of Physiology. Renal Physiology. 280 (4): F667 – F674. doi:10.1152/ajprenal.2001.280.4.F667. PMID 11249858. S2CID 26145407.
Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). "Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival". The Journal of Clinical Investigation. 107 (9): 1055–61. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (September 2006). "Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death". Journal of Cellular Physiology. 208 (3): 629–639. doi:10.1002/jcp.20701. PMID 16741956. S2CID 33704508.
Fisher LW, Fedarko NS (2003). "Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins". Connective Tissue Research. 44 (Suppl 1): 33–40. doi:10.1080/03008200390152061. PMID 12952171. S2CID 29910722.
Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). "Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications". The Biochemical Journal. 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). "ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate". American Journal of Physiology. Renal Physiology. 300 (3): F783 – F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). "Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP". Endocrinology. 149 (4): 1757–72. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (October 2008). "MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM". Journal of Bone and Mineral Research. 23 (10): 1638–49. doi:10.1359/jbmr.080601. PMID 18597632. S2CID 7709872.
Addison WN, Masica DL, Gray JJ, McKee MD (April 2010). "Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage". Journal of Bone and Mineral Research. 25 (4): 695–705. doi:10.1359/jbmr.090832. PMID 19775205. S2CID 25689595.
Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). "Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin". Biochemistry. 52 (31): 5167–75. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). "Roles of electrostatics and conformation in protein-crystal interactions". PLOS ONE. 5 (2): e9330. Bibcode:2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Hunter GK, O'Young J, Grohe B, Karttunen M, Goldberg HA (December 2010). "The flexible polyelectrolyte hypothesis of protein-biomineral interaction". Langmuir. 26 (24): 18639–46. doi:10.1021/la100401r. PMID 20527831.
McKee MD, Nanci A (May 1995). "Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues". Microscopy Research and Technique. 31 (1): 44–62. doi:10.1002/jemt.1070310105. PMID 7626799. S2CID 5767310.
Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S (September 1994). "Localization of osteopontin in the otoconial organs of adult rats". Hearing Research. 79 (1–2): 99–104. doi:10.1016/0378-5955(94)90131-7. PMID 7806488. S2CID 4765287.
Hincke MT, Nys Y, Gautron J, Mann K, Rodriguez-Navarro AB, McKee MD (January 2012). "The eggshell: structure, composition and mineralization". Frontiers in Bioscience. 17 (4): 1266–80. doi:10.2741/3985. PMID 22201802.
McKee MD, Nanci A, Khan SR (December 1995). "Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi". Journal of Bone and Mineral Research. 10 (12): 1913–29. doi:10.1002/jbmr.5650101211. PMID 8619372. S2CID 37508279.
O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, Hunter GK (2009). "Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals". Cells Tissues Organs. 189 (1–4): 51–55. doi:10.1159/000151724. PMID 18728346. S2CID 5534110.
Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). "Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning". The Journal of Biological Chemistry. 284 (35): 23491–501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
Sodek J, Ganss B, McKee MD (2000). "Osteopontin". Critical Reviews in Oral Biology and Medicine. 11 (3): 279–303. doi:10.1177/10454411000110030101. PMID 11021631.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). "Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix". Bone. 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257. S2CID 218909350.
McKee MD, Buss DJ, Reznikov N (March 2022). "Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization". Journal of Structural Biology. 214 (1): 107823. doi:10.1016/j.jsb.2021.107823. PMID 34915130. S2CID 245187449.
McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). "Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia". Periodontology 2000. 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
Boukpessi T, Hoac B, Coyac BR, Leger T, Garcia C, Wicart P, et al. (February 2017). "Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia". Bone. 95: 151–161. doi:10.1016/j.bone.2016.11.019. PMID 27884786.
McKee MD, Addison WN, Kaartinen MT (2005). "Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton". Cells Tissues Organs. 181 (3–4): 176–188. doi:10.1159/000091379. PMID 16612083. S2CID 40705942.
Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). "Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification". The American Journal of Pathology. 161 (6): 2035–46. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
Giachelli CM (March 1999). "Ectopic calcification: gathering hard facts about soft tissue mineralization". The American Journal of Pathology. 154 (3): 671–5. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
Kaartinen MT, Murshed M, Karsenty G, McKee MD (April 2007). "Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice". The Journal of Histochemistry and Cytochemistry. 55 (4): 375–386. doi:10.1369/jhc.6A7087.2006. PMID 17189522.
Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK (December 2008). "Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis". Rheumatology. 47 (12): 1775–9. doi:10.1093/rheumatology/ken385. PMID 18854347.
McKee MD, Nanci A (1996). "Osteopontin: an interfacial extracellular matrix protein in mineralized tissues". Connective Tissue Research. 35 (1–4): 197–205. doi:10.3109/03008209609029192. PMID 9084658.
Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, et al. (February 2008). "Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells". European Journal of Immunology. 38 (2): 489–499. doi:10.1002/eji.200737057. PMID 18200503.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (August 2005). "Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis". Toxicology and Applied Pharmacology. 207 (1): 25–38. Bibcode:2005ToxAP.207...25A. doi:10.1016/j.taap.2004.12.018. PMID 15885730.
Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, et al. (December 2007). "Role of osteopontin in neutrophil function". Immunology. 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, et al. (April 2002). "Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis". Arthritis and Rheumatism. 46 (4): 1094–1101. doi:10.1002/art.10143. PMID 11953989.
Burdo TH, Wood MR, Fox HS (June 2007). "Osteopontin prevents monocyte recirculation and apoptosis". Journal of Leukocyte Biology. 81 (6): 1504–11. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. (April 2002). "Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice". Proceedings of the National Academy of Sciences of the United States of America. 99 (7): 4556–61. Bibcode:2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Jacobs JP, Pettit AR, Shinohara ML, Jansson M, Cantor H, Gravallese EM, et al. (August 2004). "Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis". Arthritis and Rheumatism. 50 (8): 2685–94. doi:10.1002/art.20381. PMID 15334485.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. (November 2001). "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science. 294 (5547): 1731–5. Bibcode:2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059. S2CID 86208485.
Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, et al. (May 2007). "Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets". Nature Medicine. 13 (5): 570–8. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C (May 2009). "Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma". American Journal of Respiratory and Critical Care Medicine. 179 (10): 894–902. doi:10.1164/rccm.200807-1081OC. PMID 19234104.
Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, et al. (February 2011). "Osteopontin expression and relation to disease severity in human asthma". The European Respiratory Journal. 37 (2): 331–341. doi:10.1183/09031936.00017810. PMID 20562127.
Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, et al. (January 2013). "Increased levels of osteopontin in sputum supernatant of smoking asthmatics". Cytokine. 61 (1): 251–5. doi:10.1016/j.cyto.2012.10.002. PMID 23098767.
Samitas K, Zervas E, Xanthou G, Panoutsakopoulou V, Gaga M (March 2013). "Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics". Cytokine. 61 (3): 713–5. doi:10.1016/j.cyto.2012.12.028. PMID 23384656.
Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, et al. (November 2002). "Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum". Scandinavian Journal of Gastroenterology. 37 (11): 1286–95. doi:10.1080/003655202761020560. PMID 12465727. S2CID 6381267.
Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, et al. (September 2005). "Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response". Gut. 54 (9): 1254–62. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, et al. (February 2007). "High plasma osteopontin levels in patients with inflammatory bowel disease". Journal of Clinical Gastroenterology. 41 (2): 167–172. doi:10.1097/MCG.0b013e31802d6268. PMID 17245215. S2CID 25039321.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). "Osteopontin expression by CD103- dendritic cells drives intestinal inflammation". Proceedings of the National Academy of Sciences of the United States of America. 111 (9): E856 – E865. Bibcode:2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Steinman L (February 2007). "A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage". Nature Medicine. 13 (2): 139–145. doi:10.1038/nm1551. PMID 17290272. S2CID 10640379.
Clay R, Siddiqi SA (January 2019). "Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer". Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 978-0-12-819457-7. S2CID 214323538.
Clay R, Siddiqi SA (2019-01-01). "Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer". Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 978-0-12-819457-7. S2CID 214323538.
Mori R, Shaw TJ, Martin P (January 2008). "Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring". The Journal of Experimental Medicine. 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- "Gel 'to speed up wound healing'". BBC News. 22 January 2008.
- Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, et al. (March 2012). "Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer". Journal of Experimental & Clinical Cancer Research. 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
- Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). "Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities". Scientific Reports. 8 (1): 7781. Bibcode:2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
- Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H (January 2015). "Intracellular osteopontin regulates homeostasis and function of natural killer cells". Proc Natl Acad Sci U S A. 112 (2): 494–9. Bibcode:2015PNAS..112..494L. doi:10.1073/pnas.1423011112. PMC 4299239. PMID 25550515.
- Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M (February 2012). "Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells". J Clin Invest. 122 (2): 575–85. doi:10.1172/JCI61034. PMC 3266798. PMID 22251703.
- Simoes DC, Paschalidis N, Kourepini E, Panoutsakopoulou V (September 2022). "An integrin axis induces IFN-β production in plasmacytoid dendritic cells". J Cell Biol. 221 (9): e202102055. doi:10.1083/jcb.202102055. PMC 9354318. PMID 35878016.
- Singh M, Dalal S, Singh K (November 2014). "Osteopontin: At the cross-roads of myocyte survival and myocardial function". Life Sciences. 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
- Singh M, Foster CR, Dalal S, Singh K (March 2010). "Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI". Journal of Molecular and Cellular Cardiology. 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
- Shirakawa K, Sano M (July 2021). "Osteopontin in Cardiovascular Diseases". Biomolecules. 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
- Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, et al. (November 1997). "Myocardial osteopontin expression is associated with left ventricular hypertrophy". Circulation. 96 (9): 3063–71. doi:10.1161/01.CIR.96.9.3063. PMID 9386176.
- Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, et al. (March 2007). "Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model". Neurobiology of Disease. 25 (3): 473–482. doi:10.1016/j.nbd.2006.10.020. PMID 17188882. S2CID 30275400.
- Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, et al. (February 2002). "A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice". Human Molecular Genetics. 11 (3): 263–272. doi:10.1093/hmg/11.3.263. PMID 11823445.
- Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, et al. (November 2002). "Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 99 (23): 15000–5. Bibcode:2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
- Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, et al. (July 2003). "Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin". The American Journal of Pathology. 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
- Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, et al. (June 2009). "Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta". The Journal of Clinical Investigation. 119 (6): 1583–94. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
- Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, et al. (January 2011). "SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy". Neurology. 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.
- El Deeb S, Abdelnaby R, Khachab A, Bläsius K, Tingart M, Rath B (July 2016). "Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis". Hip International. 26 (4): 397–403. doi:10.5301/hipint.5000361. PMID 27229171. S2CID 40819265.
- Kang YJ, Forbes K, Carver J, Aplin JD (April 2014). "The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models". Human Reproduction. 29 (4): 739–749. doi:10.1093/humrep/det433. PMID 24442579.
- Johnson GA, Burghardt RC, Bazer FW, Spencer TE (November 2003). "Osteopontin: roles in implantation and placentation". Biology of Reproduction. 69 (5): 1458–71. doi:10.1095/biolreprod.103.020651. PMID 12890718.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000118785 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000029304 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). "Osteopontin--a possible anchor of osteoclasts to bone". Proceedings of the National Academy of Sciences of the United States of America. 87 (12): 4473–5. Bibcode:1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). "Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells". Proceedings of the National Academy of Sciences of the United States of America. 105 (20): 7235–9. Bibcode:2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). "Roles of electrostatics and conformation in protein-crystal interactions". PLOS ONE. 5 (2): e9330. Bibcode:2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (August 2005). "Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis". Toxicology and Applied Pharmacology. 207 (1): 25–38. Bibcode:2005ToxAP.207...25A. doi:10.1016/j.taap.2004.12.018. PMID 15885730.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. (April 2002). "Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice". Proceedings of the National Academy of Sciences of the United States of America. 99 (7): 4556–61. Bibcode:2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. (November 2001). "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science. 294 (5547): 1731–5. Bibcode:2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059. S2CID 86208485.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). "Osteopontin expression by CD103- dendritic cells drives intestinal inflammation". Proceedings of the National Academy of Sciences of the United States of America. 111 (9): E856 – E865. Bibcode:2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). "Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities". Scientific Reports. 8 (1): 7781. Bibcode:2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H (January 2015). "Intracellular osteopontin regulates homeostasis and function of natural killer cells". Proc Natl Acad Sci U S A. 112 (2): 494–9. Bibcode:2015PNAS..112..494L. doi:10.1073/pnas.1423011112. PMC 4299239. PMID 25550515.
Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, et al. (November 2002). "Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 99 (23): 15000–5. Bibcode:2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kalmar L, Homola D, Varga G, Tompa P (September 2012). "Structural disorder in proteins brings order to crystal growth in biomineralization". Bone. 51 (3): 528–534. doi:10.1016/j.bone.2012.05.009. PMID 22634174.
Wang KX, Denhardt DT (2008). "Osteopontin: role in immune regulation and stress responses". Cytokine & Growth Factor Reviews. 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.
Rangaswami H, Bulbule A, Kundu GC (February 2006). "Osteopontin: role in cell signaling and cancer progression". Trends in Cell Biology. 16 (2): 79–87. doi:10.1016/j.tcb.2005.12.005. PMID 16406521.
Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). "cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)". Genomics. 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876.
Kiefer MC, Bauer DM, Barr PJ (April 1989). "The cDNA and derived amino acid sequence for human osteopontin". Nucleic Acids Research. 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
Crosby AH, Edwards SJ, Murray JC, Dixon MJ (May 1995). "Genomic organization of the human osteopontin gene: exclusion of the locus from a causative role in the pathogenesis of dentinogenesis imperfecta type II". Genomics. 27 (1): 155–160. doi:10.1006/geno.1995.1018. PMID 7665163.
Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, et al. (March 2013). "Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia". Journal of Bone and Mineral Research. 28 (3): 688–699. doi:10.1002/jbmr.1766. PMID 22991293. S2CID 20840491.
Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). "Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis". The Journal of Clinical Investigation. 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
Seiffge D (December 1996). "Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats". The Journal of Rheumatology. 23 (12): 2086–91. PMID 8970045.
Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). "Osteopontin--a possible anchor of osteoclasts to bone". Proceedings of the National Academy of Sciences of the United States of America. 87 (12): 4473–5. Bibcode:1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Banerjee A, Apte UM, Smith R, Ramaiah SK (March 2006). "Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease". The Journal of Pathology. 208 (4): 473–485. doi:10.1002/path.1917. PMID 16440289. S2CID 45879742.
Sodek J, Batista Da Silva AP, Zohar R (May 2006). "Osteopontin and mucosal protection". Journal of Dental Research. 85 (5): 404–415. doi:10.1177/154405910608500503. PMID 16632752. S2CID 25898774.^{[permanent dead link‍]}
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (July 2000). "Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration". Journal of Cellular Physiology. 184 (1): 118–130. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. PMID 10825241. S2CID 11548419.
Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (August 2002). "Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts". Journal of Bone and Mineral Research. 17 (8): 1486–97. doi:10.1359/jbmr.2002.17.8.1486. PMID 12162503. S2CID 21307088.
Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J (January 2004). "Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin". Journal of Cellular Physiology. 198 (1): 155–167. doi:10.1002/jcp.10394. PMID 14584055. S2CID 21075107.
Junaid A, Moon MC, Harding GE, Zahradka P (February 2007). "Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1". American Journal of Physiology. Cell Physiology. 292 (2): C919 – C926. doi:10.1152/ajpcell.00477.2006. PMID 17005603.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). "Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells". Proceedings of the National Academy of Sciences of the United States of America. 105 (20): 7235–9. Bibcode:2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
He B, Mirza M, Weber GF (April 2006). "An osteopontin splice variant induces anchorage independence in human breast cancer cells". Oncogene. 25 (15): 2192–2202. doi:10.1038/sj.onc.1209248. PMID 16288209. S2CID 6632395.
Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF (February 2008). "Osteopontin-c is a selective marker of breast cancer". International Journal of Cancer. 122 (4): 889–897. doi:10.1002/ijc.23204. PMID 17960616. S2CID 22146646.
Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, et al. (November 1996). "Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction". The Journal of Clinical Investigation. 98 (10): 2218–27. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
Murry CE, Giachelli CM, Schwartz SM, Vracko R (December 1994). "Macrophages express osteopontin during repair of myocardial necrosis". The American Journal of Pathology. 145 (6): 1450–62. PMC 1887495. PMID 7992848.
Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). "Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta". The Journal of Clinical Investigation. 92 (6): 2814–20. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, Pagel CN (April 2008). "Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro". The International Journal of Biochemistry & Cell Biology. 40 (10): 2303–14. doi:10.1016/j.biocel.2008.03.020. PMID 18490187.
Merry K, Dodds R, Littlewood A, Gowen M (April 1993). "Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone". Journal of Cell Science. 104 (4): 1013–20. doi:10.1242/jcs.104.4.1013. PMID 8314886.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (January 2002). "The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation". Cell. 108 (1): 17–29. doi:10.1016/S0092-8674(01)00622-5. PMID 11792318. S2CID 14030684.
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (May 1997). "Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation". Cell. 89 (5): 747–754. doi:10.1016/S0092-8674(00)80257-3. PMID 9182762. S2CID 16979723.
Yucha C, Guthrie D (December 2003). "Renal homeostasis of calcium". Nephrology Nursing Journal. 30 (6): 755–764. PMID 14730782.
Prince CW, Butler WT (September 1987). "1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells". Collagen and Related Research. 7 (4): 305–313. doi:10.1016/s0174-173x(87)80036-5. PMID 3478171.
Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). "Regulation of bone sialoprotein mRNA by steroid hormones". The Journal of Cell Biology. 109 (6 Pt 1): 3183–6. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
Chang PL, Prince CW (April 1991). "1 alpha,25-dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells". Cancer Research. 51 (8): 2144–50. PMID 2009532.
Pereira TA, Vaz de Melo Trindade G, Trindade Santos E, Pereira FE, Souza MM (May 2021). "Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni". International Journal for Parasitology. 51 (6): 437–440. doi:10.1016/j.ijpara.2020.11.002. PMID 33493521. S2CID 231711719.
Gill HS, LeJambre LF (1996). "Preface — Novel approaches to the control of helminth parasites of livestock. Proceedings of an international conference. Armidale, New South Wales, 18-21 April 1995". Int J Parasitol. 26 (8–9): 797–8. doi:10.1016/S0020-7519(96)80042-7. PMID 8923128.
Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). "Phosphate regulates osteopontin gene transcription". Journal of Dental Research. 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
Guo H, Cai CQ, Schroeder RA, Kuo PC (January 2001). "Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages". Journal of Immunology. 166 (2): 1079–86. doi:10.4049/jimmunol.166.2.1079. PMID 11145688.
Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR (May 2000). "Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells". American Journal of Physiology. Renal Physiology. 278 (5): F708 – F716. doi:10.1152/ajprenal.2000.278.5.F708. PMID 10807582.
Noda M, Rodan GA (February 1989). "Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone". The Journal of Cell Biology. 108 (2): 713–8. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ (January 2001). "TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements". Experimental Cell Research. 262 (1): 69–74. doi:10.1006/excr.2000.5074. PMID 11120606.
Sodhi CP, Phadke SA, Batlle D, Sahai A (April 2001). "Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin". American Journal of Physiology. Renal Physiology. 280 (4): F667 – F674. doi:10.1152/ajprenal.2001.280.4.F667. PMID 11249858. S2CID 26145407.
Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). "Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival". The Journal of Clinical Investigation. 107 (9): 1055–61. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
Standal T, Borset M, Sundan A (September 2004). "Role of osteopontin in adhesion, migration, cell survival and bone remodeling". Experimental Oncology. 26 (3): 179–184. PMID 15494684.
Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (September 2006). "Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death". Journal of Cellular Physiology. 208 (3): 629–639. doi:10.1002/jcp.20701. PMID 16741956. S2CID 33704508.
Fisher LW, Fedarko NS (2003). "Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins". Connective Tissue Research. 44 (Suppl 1): 33–40. doi:10.1080/03008200390152061. PMID 12952171. S2CID 29910722.
Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). "Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications". The Biochemical Journal. 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). "ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate". American Journal of Physiology. Renal Physiology. 300 (3): F783 – F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). "Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP". Endocrinology. 149 (4): 1757–72. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (October 2008). "MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM". Journal of Bone and Mineral Research. 23 (10): 1638–49. doi:10.1359/jbmr.080601. PMID 18597632. S2CID 7709872.
Addison WN, Masica DL, Gray JJ, McKee MD (April 2010). "Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage". Journal of Bone and Mineral Research. 25 (4): 695–705. doi:10.1359/jbmr.090832. PMID 19775205. S2CID 25689595.
Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). "Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin". Biochemistry. 52 (31): 5167–75. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). "Roles of electrostatics and conformation in protein-crystal interactions". PLOS ONE. 5 (2): e9330. Bibcode:2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Hunter GK, O'Young J, Grohe B, Karttunen M, Goldberg HA (December 2010). "The flexible polyelectrolyte hypothesis of protein-biomineral interaction". Langmuir. 26 (24): 18639–46. doi:10.1021/la100401r. PMID 20527831.
McKee MD, Nanci A (May 1995). "Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues". Microscopy Research and Technique. 31 (1): 44–62. doi:10.1002/jemt.1070310105. PMID 7626799. S2CID 5767310.
Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S (September 1994). "Localization of osteopontin in the otoconial organs of adult rats". Hearing Research. 79 (1–2): 99–104. doi:10.1016/0378-5955(94)90131-7. PMID 7806488. S2CID 4765287.
Hincke MT, Nys Y, Gautron J, Mann K, Rodriguez-Navarro AB, McKee MD (January 2012). "The eggshell: structure, composition and mineralization". Frontiers in Bioscience. 17 (4): 1266–80. doi:10.2741/3985. PMID 22201802.
McKee MD, Nanci A, Khan SR (December 1995). "Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi". Journal of Bone and Mineral Research. 10 (12): 1913–29. doi:10.1002/jbmr.5650101211. PMID 8619372. S2CID 37508279.
O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, Hunter GK (2009). "Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals". Cells Tissues Organs. 189 (1–4): 51–55. doi:10.1159/000151724. PMID 18728346. S2CID 5534110.
Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). "Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning". The Journal of Biological Chemistry. 284 (35): 23491–501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
Sodek J, Ganss B, McKee MD (2000). "Osteopontin". Critical Reviews in Oral Biology and Medicine. 11 (3): 279–303. doi:10.1177/10454411000110030101. PMID 11021631.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). "Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix". Bone. 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257. S2CID 218909350.
McKee MD, Buss DJ, Reznikov N (March 2022). "Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization". Journal of Structural Biology. 214 (1): 107823. doi:10.1016/j.jsb.2021.107823. PMID 34915130. S2CID 245187449.
McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). "Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia". Periodontology 2000. 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
Boukpessi T, Hoac B, Coyac BR, Leger T, Garcia C, Wicart P, et al. (February 2017). "Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia". Bone. 95: 151–161. doi:10.1016/j.bone.2016.11.019. PMID 27884786.
McKee MD, Addison WN, Kaartinen MT (2005). "Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton". Cells Tissues Organs. 181 (3–4): 176–188. doi:10.1159/000091379. PMID 16612083. S2CID 40705942.
Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). "Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification". The American Journal of Pathology. 161 (6): 2035–46. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
Giachelli CM (March 1999). "Ectopic calcification: gathering hard facts about soft tissue mineralization". The American Journal of Pathology. 154 (3): 671–5. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
Kaartinen MT, Murshed M, Karsenty G, McKee MD (April 2007). "Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice". The Journal of Histochemistry and Cytochemistry. 55 (4): 375–386. doi:10.1369/jhc.6A7087.2006. PMID 17189522.
Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK (December 2008). "Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis". Rheumatology. 47 (12): 1775–9. doi:10.1093/rheumatology/ken385. PMID 18854347.
McKee MD, Nanci A (1996). "Osteopontin: an interfacial extracellular matrix protein in mineralized tissues". Connective Tissue Research. 35 (1–4): 197–205. doi:10.3109/03008209609029192. PMID 9084658.
Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, et al. (February 2008). "Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells". European Journal of Immunology. 38 (2): 489–499. doi:10.1002/eji.200737057. PMID 18200503.
Crawford HC, Matrisian LM, Liaw L (November 1998). "Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo". Cancer Research. 58 (22): 5206–15. PMID 9823334.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (August 2005). "Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis". Toxicology and Applied Pharmacology. 207 (1): 25–38. Bibcode:2005ToxAP.207...25A. doi:10.1016/j.taap.2004.12.018. PMID 15885730.
Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, et al. (December 2007). "Role of osteopontin in neutrophil function". Immunology. 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, et al. (April 2002). "Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis". Arthritis and Rheumatism. 46 (4): 1094–1101. doi:10.1002/art.10143. PMID 11953989.
Sakata M, Tsuruha JI, Masuko-Hongo K, Nakamura H, Matsui T, Sudo A, et al. (July 2001). "Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis". The Journal of Rheumatology. 28 (7): 1492–5. PMID 11469452.
Burdo TH, Wood MR, Fox HS (June 2007). "Osteopontin prevents monocyte recirculation and apoptosis". Journal of Leukocyte Biology. 81 (6): 1504–11. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. (April 2002). "Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice". Proceedings of the National Academy of Sciences of the United States of America. 99 (7): 4556–61. Bibcode:2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Jacobs JP, Pettit AR, Shinohara ML, Jansson M, Cantor H, Gravallese EM, et al. (August 2004). "Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis". Arthritis and Rheumatism. 50 (8): 2685–94. doi:10.1002/art.20381. PMID 15334485.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. (November 2001). "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science. 294 (5547): 1731–5. Bibcode:2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059. S2CID 86208485.
Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, et al. (May 2007). "Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets". Nature Medicine. 13 (5): 570–8. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C (May 2009). "Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma". American Journal of Respiratory and Critical Care Medicine. 179 (10): 894–902. doi:10.1164/rccm.200807-1081OC. PMID 19234104.
Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, et al. (February 2011). "Osteopontin expression and relation to disease severity in human asthma". The European Respiratory Journal. 37 (2): 331–341. doi:10.1183/09031936.00017810. PMID 20562127.
Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, et al. (January 2013). "Increased levels of osteopontin in sputum supernatant of smoking asthmatics". Cytokine. 61 (1): 251–5. doi:10.1016/j.cyto.2012.10.002. PMID 23098767.
Samitas K, Zervas E, Xanthou G, Panoutsakopoulou V, Gaga M (March 2013). "Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics". Cytokine. 61 (3): 713–5. doi:10.1016/j.cyto.2012.12.028. PMID 23384656.
Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, et al. (November 2002). "Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum". Scandinavian Journal of Gastroenterology. 37 (11): 1286–95. doi:10.1080/003655202761020560. PMID 12465727. S2CID 6381267.
Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, et al. (September 2005). "Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response". Gut. 54 (9): 1254–62. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, et al. (February 2007). "High plasma osteopontin levels in patients with inflammatory bowel disease". Journal of Clinical Gastroenterology. 41 (2): 167–172. doi:10.1097/MCG.0b013e31802d6268. PMID 17245215. S2CID 25039321.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). "Osteopontin expression by CD103- dendritic cells drives intestinal inflammation". Proceedings of the National Academy of Sciences of the United States of America. 111 (9): E856 – E865. Bibcode:2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Steinman L (February 2007). "A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage". Nature Medicine. 13 (2): 139–145. doi:10.1038/nm1551. PMID 17290272. S2CID 10640379.
Mori R, Shaw TJ, Martin P (January 2008). "Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring". The Journal of Experimental Medicine. 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- "Gel 'to speed up wound healing'". BBC News. 22 January 2008.
- Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, et al. (March 2012). "Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer". Journal of Experimental & Clinical Cancer Research. 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
- Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). "Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities". Scientific Reports. 8 (1): 7781. Bibcode:2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
- Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H (January 2015). "Intracellular osteopontin regulates homeostasis and function of natural killer cells". Proc Natl Acad Sci U S A. 112 (2): 494–9. Bibcode:2015PNAS..112..494L. doi:10.1073/pnas.1423011112. PMC 4299239. PMID 25550515.
- Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M (February 2012). "Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells". J Clin Invest. 122 (2): 575–85. doi:10.1172/JCI61034. PMC 3266798. PMID 22251703.
- Simoes DC, Paschalidis N, Kourepini E, Panoutsakopoulou V (September 2022). "An integrin axis induces IFN-β production in plasmacytoid dendritic cells". J Cell Biol. 221 (9): e202102055. doi:10.1083/jcb.202102055. PMC 9354318. PMID 35878016.
- Singh M, Dalal S, Singh K (November 2014). "Osteopontin: At the cross-roads of myocyte survival and myocardial function". Life Sciences. 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
- Singh M, Foster CR, Dalal S, Singh K (March 2010). "Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI". Journal of Molecular and Cellular Cardiology. 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
- Shirakawa K, Sano M (July 2021). "Osteopontin in Cardiovascular Diseases". Biomolecules. 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
- Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, et al. (November 1997). "Myocardial osteopontin expression is associated with left ventricular hypertrophy". Circulation. 96 (9): 3063–71. doi:10.1161/01.CIR.96.9.3063. PMID 9386176.
- Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, et al. (March 2007). "Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model". Neurobiology of Disease. 25 (3): 473–482. doi:10.1016/j.nbd.2006.10.020. PMID 17188882. S2CID 30275400.
- Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, et al. (February 2002). "A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice". Human Molecular Genetics. 11 (3): 263–272. doi:10.1093/hmg/11.3.263. PMID 11823445.
- Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, et al. (November 2002). "Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 99 (23): 15000–5. Bibcode:2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
- Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, et al. (July 2003). "Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin". The American Journal of Pathology. 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
- Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, et al. (June 2009). "Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta". The Journal of Clinical Investigation. 119 (6): 1583–94. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
- Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, et al. (January 2011). "SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy". Neurology. 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.
- El Deeb S, Abdelnaby R, Khachab A, Bläsius K, Tingart M, Rath B (July 2016). "Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis". Hip International. 26 (4): 397–403. doi:10.5301/hipint.5000361. PMID 27229171. S2CID 40819265.
- Kang YJ, Forbes K, Carver J, Aplin JD (April 2014). "The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models". Human Reproduction. 29 (4): 739–749. doi:10.1093/humrep/det433. PMID 24442579.
- Johnson GA, Burghardt RC, Bazer FW, Spencer TE (November 2003). "Osteopontin: roles in implantation and placentation". Biology of Reproduction. 69 (5): 1458–71. doi:10.1095/biolreprod.103.020651. PMID 12890718.
ncbi.nlm.nih.gov
- "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- "Entrez Gene: SPP1 secreted phosphoprotein 1".
- Kiefer MC, Bauer DM, Barr PJ (April 1989). "The cDNA and derived amino acid sequence for human osteopontin". Nucleic Acids Research. 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
- Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). "Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis". The Journal of Clinical Investigation. 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
- Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). "Osteopontin--a possible anchor of osteoclasts to bone". Proceedings of the National Academy of Sciences of the United States of America. 87 (12): 4473–5. Bibcode:1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
- Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). "Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells". Proceedings of the National Academy of Sciences of the United States of America. 105 (20): 7235–9. Bibcode:2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
- Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, et al. (November 1996). "Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction". The Journal of Clinical Investigation. 98 (10): 2218–27. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
- Murry CE, Giachelli CM, Schwartz SM, Vracko R (December 1994). "Macrophages express osteopontin during repair of myocardial necrosis". The American Journal of Pathology. 145 (6): 1450–62. PMC 1887495. PMID 7992848.
- Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). "Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta". The Journal of Clinical Investigation. 92 (6): 2814–20. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
- Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). "Regulation of bone sialoprotein mRNA by steroid hormones". The Journal of Cell Biology. 109 (6 Pt 1): 3183–6. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
- Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). "Phosphate regulates osteopontin gene transcription". Journal of Dental Research. 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
- Noda M, Rodan GA (February 1989). "Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone". The Journal of Cell Biology. 108 (2): 713–8. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
- Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). "Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival". The Journal of Clinical Investigation. 107 (9): 1055–61. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
- Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). "Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications". The Biochemical Journal. 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
- David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). "ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate". American Journal of Physiology. Renal Physiology. 300 (3): F783 – F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
- Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). "Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP". Endocrinology. 149 (4): 1757–72. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
- Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). "Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin". Biochemistry. 52 (31): 5167–75. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
- Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). "Roles of electrostatics and conformation in protein-crystal interactions". PLOS ONE. 5 (2): e9330. Bibcode:2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
- Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). "Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning". The Journal of Biological Chemistry. 284 (35): 23491–501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
- McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). "Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia". Periodontology 2000. 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
- Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). "Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification". The American Journal of Pathology. 161 (6): 2035–46. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
- Giachelli CM (March 1999). "Ectopic calcification: gathering hard facts about soft tissue mineralization". The American Journal of Pathology. 154 (3): 671–5. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
- Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, et al. (December 2007). "Role of osteopontin in neutrophil function". Immunology. 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
- Burdo TH, Wood MR, Fox HS (June 2007). "Osteopontin prevents monocyte recirculation and apoptosis". Journal of Leukocyte Biology. 81 (6): 1504–11. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
- Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, et al. (April 2002). "Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice". Proceedings of the National Academy of Sciences of the United States of America. 99 (7): 4556–61. Bibcode:2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
- Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, et al. (May 2007). "Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets". Nature Medicine. 13 (5): 570–8. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
- Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, et al. (September 2005). "Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response". Gut. 54 (9): 1254–62. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
- Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). "Osteopontin expression by CD103- dendritic cells drives intestinal inflammation". Proceedings of the National Academy of Sciences of the United States of America. 111 (9): E856 – E865. Bibcode:2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
- Mori R, Shaw TJ, Martin P (January 2008). "Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring". The Journal of Experimental Medicine. 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
  - "Gel 'to speed up wound healing'". BBC News. 22 January 2008.
  - Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, et al. (March 2012). "Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer". Journal of Experimental & Clinical Cancer Research. 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
  - Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). "Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities". Scientific Reports. 8 (1): 7781. Bibcode:2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
  - Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H (January 2015). "Intracellular osteopontin regulates homeostasis and function of natural killer cells". Proc Natl Acad Sci U S A. 112 (2): 494–9. Bibcode:2015PNAS..112..494L. doi:10.1073/pnas.1423011112. PMC 4299239. PMID 25550515.
  - Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M (February 2012). "Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells". J Clin Invest. 122 (2): 575–85. doi:10.1172/JCI61034. PMC 3266798. PMID 22251703.
  - Simoes DC, Paschalidis N, Kourepini E, Panoutsakopoulou V (September 2022). "An integrin axis induces IFN-β production in plasmacytoid dendritic cells". J Cell Biol. 221 (9): e202102055. doi:10.1083/jcb.202102055. PMC 9354318. PMID 35878016.
  - Singh M, Dalal S, Singh K (November 2014). "Osteopontin: At the cross-roads of myocyte survival and myocardial function". Life Sciences. 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
  - Singh M, Foster CR, Dalal S, Singh K (March 2010). "Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI". Journal of Molecular and Cellular Cardiology. 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
  - Shirakawa K, Sano M (July 2021). "Osteopontin in Cardiovascular Diseases". Biomolecules. 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
  - Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, et al. (November 2002). "Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 99 (23): 15000–5. Bibcode:2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
  - Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, et al. (July 2003). "Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin". The American Journal of Pathology. 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
  - Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, et al. (June 2009). "Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta". The Journal of Clinical Investigation. 119 (6): 1583–94. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
  - Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, et al. (January 2011). "SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy". Neurology. 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.

rutgers.edu

hdl.rutgers.edu

Wang KX, Denhardt DT (2008). "Osteopontin: role in immune regulation and stress responses". Cytokine & Growth Factor Reviews. 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.

semanticscholar.org

api.semanticscholar.org

Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, et al. (March 2013). "Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia". Journal of Bone and Mineral Research. 28 (3): 688–699. doi:10.1002/jbmr.1766. PMID 22991293. S2CID 20840491.
Banerjee A, Apte UM, Smith R, Ramaiah SK (March 2006). "Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease". The Journal of Pathology. 208 (4): 473–485. doi:10.1002/path.1917. PMID 16440289. S2CID 45879742.
Sodek J, Batista Da Silva AP, Zohar R (May 2006). "Osteopontin and mucosal protection". Journal of Dental Research. 85 (5): 404–415. doi:10.1177/154405910608500503. PMID 16632752. S2CID 25898774.^{[permanent dead link‍]}
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (July 2000). "Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration". Journal of Cellular Physiology. 184 (1): 118–130. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. PMID 10825241. S2CID 11548419.
Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (August 2002). "Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts". Journal of Bone and Mineral Research. 17 (8): 1486–97. doi:10.1359/jbmr.2002.17.8.1486. PMID 12162503. S2CID 21307088.
Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J (January 2004). "Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin". Journal of Cellular Physiology. 198 (1): 155–167. doi:10.1002/jcp.10394. PMID 14584055. S2CID 21075107.
He B, Mirza M, Weber GF (April 2006). "An osteopontin splice variant induces anchorage independence in human breast cancer cells". Oncogene. 25 (15): 2192–2202. doi:10.1038/sj.onc.1209248. PMID 16288209. S2CID 6632395.
Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF (February 2008). "Osteopontin-c is a selective marker of breast cancer". International Journal of Cancer. 122 (4): 889–897. doi:10.1002/ijc.23204. PMID 17960616. S2CID 22146646.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (January 2002). "The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation". Cell. 108 (1): 17–29. doi:10.1016/S0092-8674(01)00622-5. PMID 11792318. S2CID 14030684.
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (May 1997). "Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation". Cell. 89 (5): 747–754. doi:10.1016/S0092-8674(00)80257-3. PMID 9182762. S2CID 16979723.
Pereira TA, Vaz de Melo Trindade G, Trindade Santos E, Pereira FE, Souza MM (May 2021). "Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni". International Journal for Parasitology. 51 (6): 437–440. doi:10.1016/j.ijpara.2020.11.002. PMID 33493521. S2CID 231711719.
Sodhi CP, Phadke SA, Batlle D, Sahai A (April 2001). "Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin". American Journal of Physiology. Renal Physiology. 280 (4): F667 – F674. doi:10.1152/ajprenal.2001.280.4.F667. PMID 11249858. S2CID 26145407.
Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (September 2006). "Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death". Journal of Cellular Physiology. 208 (3): 629–639. doi:10.1002/jcp.20701. PMID 16741956. S2CID 33704508.
Fisher LW, Fedarko NS (2003). "Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins". Connective Tissue Research. 44 (Suppl 1): 33–40. doi:10.1080/03008200390152061. PMID 12952171. S2CID 29910722.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (October 2008). "MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM". Journal of Bone and Mineral Research. 23 (10): 1638–49. doi:10.1359/jbmr.080601. PMID 18597632. S2CID 7709872.
Addison WN, Masica DL, Gray JJ, McKee MD (April 2010). "Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage". Journal of Bone and Mineral Research. 25 (4): 695–705. doi:10.1359/jbmr.090832. PMID 19775205. S2CID 25689595.
McKee MD, Nanci A (May 1995). "Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues". Microscopy Research and Technique. 31 (1): 44–62. doi:10.1002/jemt.1070310105. PMID 7626799. S2CID 5767310.
Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S (September 1994). "Localization of osteopontin in the otoconial organs of adult rats". Hearing Research. 79 (1–2): 99–104. doi:10.1016/0378-5955(94)90131-7. PMID 7806488. S2CID 4765287.
McKee MD, Nanci A, Khan SR (December 1995). "Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi". Journal of Bone and Mineral Research. 10 (12): 1913–29. doi:10.1002/jbmr.5650101211. PMID 8619372. S2CID 37508279.
O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, Hunter GK (2009). "Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals". Cells Tissues Organs. 189 (1–4): 51–55. doi:10.1159/000151724. PMID 18728346. S2CID 5534110.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). "Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix". Bone. 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257. S2CID 218909350.
McKee MD, Buss DJ, Reznikov N (March 2022). "Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization". Journal of Structural Biology. 214 (1): 107823. doi:10.1016/j.jsb.2021.107823. PMID 34915130. S2CID 245187449.
McKee MD, Addison WN, Kaartinen MT (2005). "Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton". Cells Tissues Organs. 181 (3–4): 176–188. doi:10.1159/000091379. PMID 16612083. S2CID 40705942.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. (November 2001). "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science. 294 (5547): 1731–5. Bibcode:2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059. S2CID 86208485.
Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, et al. (November 2002). "Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum". Scandinavian Journal of Gastroenterology. 37 (11): 1286–95. doi:10.1080/003655202761020560. PMID 12465727. S2CID 6381267.
Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, et al. (February 2007). "High plasma osteopontin levels in patients with inflammatory bowel disease". Journal of Clinical Gastroenterology. 41 (2): 167–172. doi:10.1097/MCG.0b013e31802d6268. PMID 17245215. S2CID 25039321.
Steinman L (February 2007). "A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage". Nature Medicine. 13 (2): 139–145. doi:10.1038/nm1551. PMID 17290272. S2CID 10640379.
Clay R, Siddiqi SA (January 2019). "Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer". Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 978-0-12-819457-7. S2CID 214323538.
Clay R, Siddiqi SA (2019-01-01). "Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer". Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 978-0-12-819457-7. S2CID 214323538.
Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, et al. (March 2007). "Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model". Neurobiology of Disease. 25 (3): 473–482. doi:10.1016/j.nbd.2006.10.020. PMID 17188882. S2CID 30275400.
El Deeb S, Abdelnaby R, Khachab A, Bläsius K, Tingart M, Rath B (July 2016). "Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis". Hip International. 26 (4): 397–403. doi:10.5301/hipint.5000361. PMID 27229171. S2CID 40819265.

zenodo.org

Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). "cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)". Genomics. 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876.